Combined percutaneous treatment of atrial septal defect and pulmonic or aortic stenosis in adult patients

Tomašov, Pavol; Linhartová, Kateřina; Antonová, Petra; Adlová, Radka; Alan, David; Veselka, Josef

doi:10.5114/aoms.2010.19312

Cited by 8 publications

(11 citation statements)

References 8 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[5][6][7][8] Currently, it is already well known and accepted that ASD closure and balloon valvuloplasty of a nondysplastic pulmonary valve can both be accomplished with high rates of success using the transcatheter approach. [9][10][11] However, there is inadequate literature on the comparison of clinical results between surgical treatment and transcatheter correction of ASD combined with PS. The aim of the present study was, therefore, to compare the effects of these two procedures to correct ASD combined with PS on transvalvular gradient, functional status, tricuspid regurgitation (TR), and main complications in a middle unselected cohort in China.…”

mentioning

confidence: 99%

Comparison of Medium-term Results of Transcatheter Correction Versus Surgical Treatment for Secundum Type Atrial Septal Defect Combined With Pulmonary Valve Stenosis

Liu

Zhao

et al. 2014

Int. Heart J.

View full text Add to dashboard Cite

SummaryThis study was undertaken to compare the clinical results of traditional surgery and a percutaneous procedure for secundum type atrial septal defect (ASD) combined with pulmonary valve stenosis (PS). A total of 78 consecutive patients were identified between March 2004 and July 2012 in our institution. Thirty-five patients (44.9%) underwent percutaneous correction and the remaining 43 patients (55.1%) were treated surgically. All patients had simultaneous complete correction in both groups and no serious complications occurred. The surgical group was significantly younger (13.9 ± 13.0 versus 31.0 ± 17.5 years, P < 0.001) and had a longer mean hospital stay (12.6 ± 4.7 versus 5.3 ± 1.5 days, P < 0.001). There were no significant differences in defect size (18.0 ± 7.9 versus 16.9 ± 8.4 mm, P = 0.553) and transvalvular gradient detected by transthoracic echocardiography (TTE) (74.7 ± 28.3 versus 87.6 ± 37.8 mmHg, P = 0.089) between the two groups. Significant tricuspid regurgitation (TR) decreased from 66% to 14% in the transcatheter group and from 40% to 9% in the surgical group. Mild pulmonary regurgitation was detected in 8 patients in the transcatheter cohort and in 6 patients in the surgical cohort after the procedure. At last follow-up, 83% and 93% of the patients in the transcatheter and surgical groups, respectively, were free of any symptoms, and a significant improvement from preprocedure was observed in the transcatheter group but not in the surgical group (P = 0.005 and P = 0.062). In conclusion, transcatheter correction is a valuable alternative to surgery and allows more patients to be effectively treated in China. (Int Heart J 2014; 55: 326-330) Key words: Congenital heart disease, Pulmonary stenosis, Interventional therapy, Surgical P ulmonary valve stenosis (PS) combined with atrial septal defect (ASD) is a relatively common form of congenital heart disease. Traditional treatment for PS and ASD is open surgery, which is widely performed with low mortality and excellent early and late results, although it still carries risks, such as residual shunt, postpericardiotomy syndrome, low cardiac output syndrome (LCOS), and wound infection after cardiopulmonary bypass (CPB). In addition, formation of scar tissue after surgery is also a common concern for many patients, especially young females. Since the first successful clinical application and report in 1982, 1) percutaneous balloon pulmonary valvuloplasty (PBPV) has replaced surgery as the initial treatment of choice in patients of all ages with pure PS.2-4) Percutaneous ASD closure has become an established therapy that is performed in increasing numbers of adults and children for its good clinical and follow-up results.5-8) Currently, it is already well known and accepted that ASD closure and balloon valvuloplasty of a nondysplastic pulmonary valve can both be accomplished with high rates of success using the transcatheter approach.9-11) However, there is inadequate literature on the comparison of clinical results between surgical treatment ...

show abstract

mentioning

confidence: 99%

Comparison of Medium-term Results of Transcatheter Correction Versus Surgical Treatment for Secundum Type Atrial Septal Defect Combined With Pulmonary Valve Stenosis

Liu

Zhao

et al. 2014

Int. Heart J.

View full text Add to dashboard Cite

show abstract

“…However, the simultaneous transcatheter treatment of critical valvar PS and large ASD is rare. 1,8 The first case of combined treatment of balloon pulmonary valvuloplasty and atrial septal defect was described in 1997 by Yip et al in a 7 year old girl. 9 Recently, report on concurrent transcatheter therapy of valvar PS and secundum ASD has been increased tremendously.…”

Section: Discussionmentioning

confidence: 98%

Simultaneous transcatheter valvuloplasty and Amplatzer septal occlusion for pulmonary valvar stenosis and secundum atrial septal defect: A case report

Pawar

Kokane

Taksande

et al. 2015

Journal of Indian College of Cardiology

View full text Add to dashboard Cite

Atrial septal defectPulmonary valve stenosis a b s t r a c t Severe pulmonary valve stenosis in association with a large atrial septal defect is uncommon. Simultaneous percutaneous closure of the atrial septal defect and pulmonary valvuloplasty appears to be an attractive modality when compared to patients with these two lesions being subjected to surgery or being treated percutaneously at different sittings.We encountered a case of 40 years female, with significant pulmonary valvular stenosis associated with large 27 mm ostium secundum atrial septal defect. Both lesions were successfully treated percutaneously in the same sitting. Pulmonary valvuloplasty was done initially and the atrial septal defect closed later to minimize catheter manipulation after device implantation.

show abstract

“…In conclusion, therapy of the elderly is often problematic [ 12 , 13 ]. This refers to both management of common pathologies and congenital heart defects found in the elderly.…”

Section: Discussionmentioning

confidence: 99%

Persistent ductus arteriosus in a 72-year-old woman with paroxysmal atrial fibrillation and depression syndrome: a therapeutic and diagnostic problem

Poliwczak¹,

Koziróg²,

Zabielska³

et al. 2011

aoms

View full text Add to dashboard Cite

Treating the elderly is often problematic, especially when congenital heart disease is diagnosed. The aim of this study is to present the case of a 72-year old woman with depression syndrome, paroxysmal atrial fibrillation and past cerebral stroke, in whom persistent ductus arteriosus Botalli was diagnosed. Due to exacerbation of the depressive syndrome, she did not give her consent to further diagnostics, possible interventional procedures and treatment with oral anticoagulants. After intermission of the therapy she was treated with dabigatran. The patient is still undergoing outpatient treatment and so far, no cerebrovascular episodes have been recorded.

show abstract

Combined percutaneous treatment of atrial septal defect and pulmonic or aortic stenosis in adult patients

Cited by 8 publications

References 8 publications

Comparison of Medium-term Results of Transcatheter Correction Versus Surgical Treatment for Secundum Type Atrial Septal Defect Combined With Pulmonary Valve Stenosis

Comparison of Medium-term Results of Transcatheter Correction Versus Surgical Treatment for Secundum Type Atrial Septal Defect Combined With Pulmonary Valve Stenosis

Simultaneous transcatheter valvuloplasty and Amplatzer septal occlusion for pulmonary valvar stenosis and secundum atrial septal defect: A case report

Persistent ductus arteriosus in a 72-year-old woman with paroxysmal atrial fibrillation and depression syndrome: a therapeutic and diagnostic problem

Contact Info

Product

Resources

About